Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Upjohn Eesv🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 2, 2024
Approval ID: 225d50307e792643
Company: Upjohn Eesv
Type: Standard

Approval Details

Approval Id: 225d50307e792643
Drug Cima Aemps Name: ZARATOR 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 8194201508
Holder Company Name: Upjohn Eesv
Marketing Company Name: Elam Pharma Labs S.L.
Holder Company Detail Path: /organization/upjohn-eesv
Authorization Date: 2024-04-02
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Upjohn Eesv
Company Detail Path: /organization/upjohn-eesv

Company Information

Pharmaceutical Company Name: Upjohn EESV
Country Name: Netherlands

Active Ingredients

ATORVASTATINA

40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 2, 2024

Approval ID

225d50307e792643

Type

Standard

Back to CIMA-AEMPS Approvals